Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Theracryf PLC 04 March 2025 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Director/PDMR Shareholding Alderley Park, UK - 4 March...
Theracryf PLC 24 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name...
...
Theracryf PLC 19 February 2025 THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR...
Theracryf PLC 19 February 2025 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Experienced life sciences executive, Dr Alastair...
TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncolo ...
Theracryf PLC 28 November 2024 TheraCryf plc ("TheraCryf" or "the Company" or "the Group") Half Year Report to 30 September 2024 ...
TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug trea ...
Theracryf PLC 15 November 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name...
Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Issue of Equity and Total Voting Rights Alderley...
Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Notice of Interim results and Presentation via...
The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and ...
Theracryf PLC 04 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Passing of Dr Sue Foden, Chair Alderley Park, UK...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지